Pharmacist Intervention to Reduce Post-Hospitalization Utilization

Recruiting in Palo Alto (17 mi)

+1 other location

Overseen byJoshua Pevnick

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Cedars-Sinai Medical Center

No Placebo Group

Trial Summary

What is the purpose of this trial?This trial tests a pharmacist-led program to help older adults manage their medications after leaving the hospital. It aims to reduce readmissions and emergency visits by ensuring patients take their medicines correctly and safely.

Eligibility Criteria

This trial is for older adults (55+) who are at risk of medication issues after leaving the hospital. They must be taking more than 10 prescription meds or over three high-risk meds like blood thinners or diabetes drugs. It's not for those without stable housing, discharged out-of-state, in hospice care, previously enrolled, under certain specialists' care, or with COVID-19.

Inclusion Criteria

This criterion does not apply to me.

I am taking 10 or more prescription medications.

I am currently admitted to a hospital ward.

+2 more

Exclusion Criteria

Expected AMA or left hospital against medical advice (AMA)

I will get medication management from a pharmacist after leaving the hospital.

Expected discharge to another state, acute care facility, psychiatric facility, or locked facility (including locked skilled nursing facility, jail, or prison)

+6 more

Participant Groups

The study tests a pharmacist-led program to manage medications when patients leave the hospital. The goal is to see if this helps reduce emergency visits and readmissions within 30 days post-discharge. Patients are randomly chosen to either get this extra pharmacy help or usual care.

2Treatment groups

Experimental Treatment

Active Control

Group I: Pharmacist ArmExperimental Treatment1 Intervention

Pharmacist-Led Medication Reconciliation, Regimen Review, and Adherence and Literacy Assessment and Counseling

Group II: Usual CareActive Control1 Intervention

Patients in this study will receive usual care. Clinically-indicated services, including pharmacist services, may be provided to control group patients.